Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial
Recruiting · NCT05652673 · Registry updated 2025-02-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safe Stop Ipilimumab-nivolumab (IPI-NIVO) Trial | Chemically-Induced Disorders, Drug Toxicity, Drug-Related Side Effects and Adverse Reactions, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm | Recruiting | Not applicable | 2025-02-28 | NCT05652673 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Erasmus Medical Center | 271 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Erasmus MC | Rotterdam | Netherlands | 10 |